Literature DB >> 33818279

A NOVEL NOX/PHOX-CD38-NAADP-TFEB AXIS IMPORTANT FOR MACROPHAGE ACTIVATION DURING BACTERIAL PHAGOCYTOSIS.

Mehran Najibi1,2, Havisha H Honwad1, Joseph A Moreau1, Stephanie M Becker1, Javier E Irazoqui1.   

Abstract

Macrophage activation in the presence of bacterial cells and molecules entails complex programs of gene expression. How such triggers elicit specific gene expression programs is incompletely understood. We previously discovered that TFEB (transcription factor EB) is a key contributor to macrophage activation during bacterial phagocytosis. However, the mechanism linking phagocytosis of bacterial cells to TFEB activation and downstream pro-inflammatory cytokine induction remained unknown. We found that macrophages lacking both TFEB and TFE3 (transcription factor E3) were unable to mount a pro-inflammatory phenotype in response to bacterial infection. The NOX/PHOX (NADPH oxidase)-dependent oxidative burst was required for nuclear translocation of TFEB during phagocytosis of Gram-positive or -negative bacteria, and reactive oxygen species (ROS) were sufficient to trigger TFEB activation in a CD38- and NAADP (nicotinic acid adenine dinucleotide phosphate)-dependent manner. Consistent with the Ca2+-releasing activity of NAADP, intracellular Ca2+ chelation and PPP3/calcineurin inhibition prevented TFEB activation by phagocytosis and ROS (reactive oxygen species), impairing the induction of pro-inflammatory cytokines such as IL6 and TNF/TNFα. Therefore, here we describe a previously unknown pathway that links phagocytosis with macrophage pro-inflammatory polarization via TFEB and related transcription factor TFE3. These findings reveal that activation of TFEB and TFE3 is a key regulatory event for the activation of macrophages, and have important implications for infections, inflammation, cancer, obesity, and atherosclerosis.

Entities:  

Keywords:  CD38; il1α; il1β; il6; innate immunity; phagocyte; reactive oxygen species; tfe3; tfeb; tnfα

Mesh:

Substances:

Year:  2021        PMID: 33818279      PMCID: PMC8865266          DOI: 10.1080/15548627.2021.1911548

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  80 in total

1.  A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis.

Authors:  Mohammad Samie; Xiang Wang; Xiaoli Zhang; Andrew Goschka; Xinran Li; Xiping Cheng; Evan Gregg; Marlene Azar; Yue Zhuo; Abigail G Garrity; Qiong Gao; Susan Slaugenhaupt; Jim Pickel; Sergey N Zolov; Lois S Weisman; Guy M Lenk; Steve Titus; Marthe Bryant-Genevier; Noel Southall; Marugan Juan; Marc Ferrer; Haoxing Xu
Journal:  Dev Cell       Date:  2013-08-29       Impact factor: 12.270

Review 2.  Transcriptional control of the inflammatory response.

Authors:  Ruslan Medzhitov; Tiffany Horng
Journal:  Nat Rev Immunol       Date:  2009-10       Impact factor: 53.106

Review 3.  Emerging roles for TFEB in the immune response and inflammation.

Authors:  Owen A Brady; José A Martina; Rosa Puertollano
Journal:  Autophagy       Date:  2017-07-24       Impact factor: 16.016

4.  Ligand-induced internalization of CD38 results in intracellular Ca2+ mobilization: role of NAD+ transport across cell membranes.

Authors:  E Zocchi; C Usai; L Guida; L Franco; S Bruzzone; M Passalacqua; A De Flora
Journal:  FASEB J       Date:  1999-02       Impact factor: 5.191

5.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

6.  An Evolutionarily Conserved PLC-PKD-TFEB Pathway for Host Defense.

Authors:  Mehran Najibi; Sid Ahmed Labed; Orane Visvikis; Javier Elbio Irazoqui
Journal:  Cell Rep       Date:  2016-05-12       Impact factor: 9.423

7.  Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.

Authors:  Sabine Heumüller; Sven Wind; Eduardo Barbosa-Sicard; Harald H H W Schmidt; Rudi Busse; Katrin Schröder; Ralf P Brandes
Journal:  Hypertension       Date:  2007-12-17       Impact factor: 10.190

8.  Salmonella inhibits retrograde trafficking of mannose-6-phosphate receptors and lysosome function.

Authors:  Kieran McGourty; Teresa L Thurston; Sophie A Matthews; Laurie Pinaud; Luís Jaime Mota; David W Holden
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

9.  Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism.

Authors:  Mireille Ouimet; Stefan Koster; Erik Sakowski; Bhama Ramkhelawon; Coen van Solingen; Scott Oldebeken; Denuja Karunakaran; Cynthia Portal-Celhay; Frederick J Sheedy; Tathagat Dutta Ray; Katharine Cecchini; Philip D Zamore; Katey J Rayner; Yves L Marcel; Jennifer A Philips; Kathryn J Moore
Journal:  Nat Immunol       Date:  2016-04-18       Impact factor: 25.606

10.  Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.

Authors:  Carlos Escande; Veronica Nin; Nathan L Price; Verena Capellini; Ana P Gomes; Maria Thereza Barbosa; Luke O'Neil; Thomas A White; David A Sinclair; Eduardo N Chini
Journal:  Diabetes       Date:  2012-11-19       Impact factor: 9.461

View more
  3 in total

1.  Invading Bacterial Pathogens Activate Transcription Factor EB in Epithelial Cells through the Amino Acid Starvation Pathway of mTORC1 Inhibition.

Authors:  Liliane Cabral-Fernandes; Shawn Goyal; Armin Farahvash; Jessica Tsalikis; Dana J Philpott; Stephen E Girardin
Journal:  Mol Cell Biol       Date:  2022-08-25       Impact factor: 5.069

2.  TFEB induces mitochondrial itaconate synthesis to suppress bacterial growth in macrophages.

Authors:  Ev-Marie Schuster; Maximilian W Epple; Katharina M Glaser; Michael Mihlan; Kerstin Lucht; Julia A Zimmermann; Anna Bremser; Aikaterini Polyzou; Nadine Obier; Nina Cabezas-Wallscheid; Eirini Trompouki; Andrea Ballabio; Jörg Vogel; Joerg M Buescher; Alexander J Westermann; Angelika S Rambold
Journal:  Nat Metab       Date:  2022-07-21

Review 3.  Targeting CD38 in Neoplasms and Non-Cancer Diseases.

Authors:  Wojciech Szlasa; Jakub Czarny; Natalia Sauer; Katarzyna Rakoczy; Natalia Szymańska; Jakub Stecko; Maksymilian Kołodziej; Maciej Kaźmierczak; Ewa Barg
Journal:  Cancers (Basel)       Date:  2022-08-28       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.